Pfizer, a leading healthcare company, has seen its stock yield rise to over 7.2%. With an “A” rating from the S&P, this makes it a quality income stock. This is especially notable given that Pfizer has increased its dividend payout for 15 consecutive years, boasting a generous 54% return on investment.
Source: https://seekingalpha.com/mp/1305-macro-trading-factory/articles/6208299-trading-alerts-sept-24-2025-rig